Kelly Financial Services LLC Organon & Co. Transaction History

Kelly Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 17, 2024	BUY	$13.78 - $18.8 $13 - $18	1 Added 1.0%	101 $1,000
Q4 2023 Jul 17, 2024	BUY	$10.95 - $17.32 $10 - $17	1 Added 1.01%	100 $1.44 Million
Q3 2023 Jul 17, 2024	BUY	$16.59 - $23.77 $16 - $23	1 Added 1.02%	99 $1.72 Million
Q1 2023 Jul 17, 2024	BUY	$21.42 - $32.08 $21 - $32	1 Added 1.03%	98 $2.3 Million
Q3 2022 Jul 17, 2024	BUY	$23.4 - $34.25 $23 - $34	1 Added 1.04%	97 $2.27 Million
Q4 2021 Jul 17, 2024	BUY	$28.67 - $37.13 $28 - $37	1 Added 1.05%	96 $2.91 Million
Q3 2021 Jul 17, 2024	SELL	$28.63 - $35.64 $83,055 - $103,391	-2,901 Reduced 96.83%	95 $3.13 Million
Q2 2021 Jul 17, 2024	BUY	$28.45 - $38.0 $85,236 - $113,848	2,996 New	2,996 $99,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.06B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.